share_log

On Jan 17, Jounce Therapeutics Received Notice From Nasdaq Co. Regained Compliance With Minimum Bid Price Requirement For Continued Listing On Nasdaq

Benzinga Real-time News ·  Jan 20, 2023 08:13
on Jan 17, Jounce Therapeutics Received Notice From Nasdaq Co. Regained Compliance With Minimum Bid Price Requirement For Continued Listing On Nasdaq
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment